Stammzellen
Post-PCI Selection of Antithrombotic Therapy
Post-PCI Selection of Antithrombotic Therapy Improvements in antithrombotic pharmacotherapy have led to important reductions in complications after percutaneous coronary intervention. By John P. Vavalle, MD, and Robert A. Harrington, MD Since the introduction of percutaneous coronary intervention (PCI) more than 3 decades ago, the rates of procedural success and associated Weiterlesen
